Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 1999

View Archived Issues

One-year NINDS study results on t-PA for acute ischemic stroke

Ferrer to market Ortec's Composite Cultured Skin in Spain

PowderJect development update and preliminary year-end results

Results announced for CytoTherapeutics' pain control implant study

Antiarrhythmic drug to move into phase II trials at CV Therapeutics

BioCryst receives milestone payment from Ortho-McNeil

Fosamax receives FDA approval for glucocorticoid-induced osteoporosis

Magainin begins phase II testing of squalamine

News from ADA: pentoxifylline improves insulin sensitivity in patients with poor glycemic control

Ligand submits NDA for Targretin capsules and reports positive interim data from psoriasis study

The nontriptan antimigraine agent SB-220453 has a novel mechanism, no vasoconstrictor activity

SA-6541 effective in animal models of arthritis and dermatitis, as reported at ongoing congress

Roberts buys rights to Agrylin from Bristol-Myers Squibb

Orphan Medical's Antizol injection receives approval in the U.K.

Adenosine binding and uptake inhibitors in the Kyowa Hakko pipeline

Sumitomo presents new inhibitors of STAT6 activation

Antiischemic and cytoprotective agents from Taisho act via inhibition of Na+/Ca2+ exchange

Continued focus at Merck on inhibitors of protein farnesyltransferase

Frovatriptan shows excellent efficacy and safety in thousands of patients treated

IntraBiotics prepares safer new threonine-containing protegrin peptide antibiotics

3M presents new inhibitors of 5-LO and their use

Substituted imidazoles for glaucoma, pain, etc., in early development at Allergan

Effective and safe antiinflammatory agent with dual mechanism of action presented at congress

24-hour headache recurrence is significantly lower with eletriptan than with other triptans

Preclinical profile suggests that cipamfylline is a promising candidate for atopic dermatitis

Ares-Serono's Gonal-F receives E.U. approval as treatment of male infertility

Bradykinin mimic reduces myocardial infarct size in rat model

S-33516: promising new COX-2-selective antiinflammatory for rheumatic diseases

Data presented at World Congress on Inflammation suggest potential of adefovir in RA

Antiinflammatory mechanism(s) of orazipone undergoes study at Orion

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...